R(-)3-quinuclidinol derivatives
US5164386A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 20, 1990 |
| Grant date | Nov 17, 1992 |
| Priority date | — |
| Expiry date | Jun 20, 2010 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmacologically active R(-) 3-quinuclidinol derivatives are described which are muscarinic receptor blocking agents useful for the treatment of gastrointestinal and respiratory tract disorders of the following formula (I) ##STR1## wherein R represents a linear or branched lower alkyl group, a cycloalkyl-C.sub.1-2 alkyl or an aralkyl group, or it is absent; PA0 X represents the anion of an organic or inorganic acid, or it is absent, when R is absent; PA0 R.sub.1 represents H, a linear or branched lower alkyl group or an acyl group of the type R.sub.2 --CO, in which R.sub.2 is H or a linear or branched lower alkyl group; PA0 A represents a cycloalkyl, an aromatic ring or a 5- or 6-membered heterocyclic ring; PA0 Y and Z may be simultaneously or alternatively present or absent; when they are simultaneously present, they represent oxygen; when only one of them is present, it is oxygen or sulphur; PA0 n is 1, 2 or 3; PA0 A and the 3-quinuclidinyl ester groups are inserted simultaneously on the same carbon atom of the ring to give rise to a geminal substitution. The process for the preparation of the compounds of formula (I) as well as pharmaceutical compositions containing them are al…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.